Jonathan Violin - Dec 8, 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director
Signature
/s/ Lara Meisner, Attorney-in-Fact for Jonathan Violin
Stock symbol
VRDN
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 05:08 PM
Previous filing
Sep 22, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRDN Common Stock Conversion of derivative security $0 +628K +18783.72% $0.00 631K Dec 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Series A Non-Voting Convertible Preferred Stock Conversion of derivative security $0 -9.41K -100% $0.00* 0 Dec 8, 2021 Common Stock 628K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Non-Voting Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 66.67 shares of Common Stock, subject to certain limitations.

Remarks:

President and Chief Executive Officer Exhibit 24 - Power of Attorney